Skip to content

Clinical trials

Dermatomyositis trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Country / region: Czechia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20111
20131
20172
20181
20202
20222
20233
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Terminated3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chugai Pharmaceutical2
Kezar Life Sciences, Inc.2
Novartis Pharmaceuticals2
argenx2
AstraZeneca1
Bristol-Myers Squibb1
Corbus Pharmaceuticals Inc.1
EMD Serono Research & Development Institute, Inc.1
Institute of Rheumatology, Prague1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis19
Polymyositis12
Myositis8
Musculoskeletal Diseases3
Antiphospholipid Syndrome2
Behcet Syndrome2
Muscular Diseases2
Pemphigoid, Bullous2
Purpura, Thrombocytopenic, Idiopathic2
Arthritis, Rheumatoid1

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.